Madec Y, Szumilin E, Genevier C, Ferradini LLF, Balkan S, et al.
2009-04-27 • AIDS
2009-04-27 • AIDS
BACKGROUND In developing countries, access to laboratory tests remains limited, and the use of simple tools such as weight to monitor HIV-infected patients treated with antiretrovira...
Pouillot R, Matias G, Wondje CM, Portaels F, Valin N, et al.
2007-12-19 • PLOS Neglected Tropical Diseases
2007-12-19 • PLOS Neglected Tropical Diseases
BACKGROUND: Buruli ulcer is an infectious disease involving the skin, caused by Mycobacterium ulcerans. This disease is associated with areas where the water is slow-flowing or stagnant....
Fontanet AL, McCauley RG, Coyette Y, Larchiver F, Bennish ML
1993-12-01 • American Journal of Tropical Medicine and Hygiene
1993-12-01 • American Journal of Tropical Medicine and Hygiene
To determine the incidence, outcome, and optimal management of empyema, all children less than 15 years of age admitted to Khao-I-Dang Hospital with a diagnosis of empyema during a 23-mo...
Borand L, Madec Y, Laureillard D, Chou M, Marcy O, et al.
2014-03-07 • PLOS One
2014-03-07 • PLOS One
OBJECTIVE To assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients.
Madec Y, Laureillard D, Pinoges LLP, Fernandez MAL, Prak N, et al.
2007-01-30 • AIDS
2007-01-30 • AIDS
BACKGROUND: HAART efficacy was evaluated in a real-life setting in Phnom Penh (Médecins Sans Frontières programme) among severely immuno-compromised patients. METHODS: Factors associated...
